In the last 200 years, a small number of homeopaths have achieved clinical results that are unprecedented in the entire history of medicine.
Hahnemann, Lippe, Bœnninghausen, Wells, Hering, Dunham, Guernsey, Nash, Wilson, Taylor, Yingling and others are just a few of these remarkable giants of medicine, the great homeopaths of the past. Their writings, their results and their clinical approach have been the focus of Dr. Andre Saine’s life’s work for more than 30 years and they are the focus of the resources available through the Canadian Academy of Homeopathy (CAH) and this website.
The objective of the Academy is to provide homeopathic training for health care professionals that provides a solid foundation in the principles of pure homeopathy as practiced by the great masters of the past.
The Canadian Academy of Homeopathy (CAH) is a homeopathic school founded in 1986 by a group of naturopathic physicians eager to provide training in homeopathy of the highest level and standards. Since that time, the Academy has offered four postgraduate fellowship programs in homeopathy of three years duration, a postgraduate residency program in homeopathy, a research program and a program of continuing homeopathic education for homeopaths around the world.
The resources on this site will provide practitioners with a foundation unparalleled in homeopathy, beginning with history and philosophy, then case taking, case analysis, repertorization, the prescription, follow-up and extensive comparative materia medica.
A 2 hour course about the many strategies available to us to prevent Alzheimer’s disease.
If you’re 45+ or you have a parent with Alzheimer’s disease, this material is particularly relevant for you!
Did you know that:
50% of people will be diagnosed with Alzheimer’s by age 85, though the disease starts decades before symptoms appear.
It is the fasting growing disease and the 3rd leading cause of mortality in developed countries.
Despite the billions of dollars spent on research, there is still neither a cure nor an effective treatment for the disease, which invariably progresses to death.
There is a genetic component to Alzheimer’s disease that increases risk – and it's easy to test whether you have the gene - and the extra measures for prevention if needed.